Pediatric Emergency Medicine Simulation Curriculum: Vitamin K Deficiency in the Newborn

Elizabeth Sanseau1, Leah H Carr2, Jennifer Case3

  • 1Fellow, Pediatric Emergency Medicine, Children's Hospital of Philadelphia.

Insights

Vitamin K prophylaxis is recommended for newborns to prevent vitamin K deficiency bleeding (VKDB). A simulation effectively trained physicians to recognize and manage infants with VKDB, improving medical management skills.

Area of Science:

  • Pediatrics
  • Neonatology
  • Medical Simulation

Background:

  • Vitamin K prophylaxis at birth is recommended for all newborns by the American Academy of Pediatrics to prevent vitamin K deficiency bleeding (VKDB).
  • Barriers to prophylaxis, such as parental refusal, are increasing, coinciding with a rise in VKDB cases.
  • There is a lack of evidence for serious harms associated with vitamin K prophylaxis.

Purpose of the Study:

  • To develop and evaluate a medical simulation for training physicians in the recognition and management of vitamin K deficiency bleeding (VKDB) in infants.
  • To assess the perceived effectiveness of the simulation as a learning tool for pediatric and emergency providers.

Main Methods:

  • A simulated case of an infant with cerebral hemorrhage due to VKDB was developed for emergency department presentation.
  • The simulation was integrated into pediatric and emergency medicine curricula at five institutions over one year.
  • Participants (40 fellows, 8 attendings) completed post-simulation surveys to evaluate relevance and impact on medical management.

Main Results:

  • The simulation involved 48 participants across five training institutions.
  • Ninety-four percent of participants rated the simulation as highly relevant.
  • Over 80% reported that the simulation experience improved their medical management skills.

Conclusions:

  • The developed simulation is an effective educational tool for training physicians to recognize and manage infants with VKDB.
  • The simulation successfully prepared pediatric and emergency providers for critical care scenarios involving VKDB.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
106
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
103
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
128
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89